Did you also think the chance of MYL’s trying to get FDA approval for Natco’s Copaxone knockoff was close to zero? (Rhetorical question—no need to reply.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”